Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis Participants
Clinical trial NCT02052310 · COMPLETED
Trial details
- NCT number
- NCT02052310
- Sponsor
- Kyntra Bio
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-11
- Primary completion
- 2018-09-21
- Enrollment
- 1043
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.